GL1X · GenesisL1 explorer

MolNFT v1 · #91545 · protein

S. aureus dihydrofolate reductase co-crystallized with ethyl-dap isobutenyl-dihydrophthalazine inhibitor

4FGH: “S. aureus dihydrofolate reductase co-crystallized with ethyl-dap isobutenyl-dihydrophthalazine inhibitor”. X-ray diffraction, 2 ligands (NAP, 0U6), 1 pocket (best druggability 0.69). MolNFT v1 #91545 on GenesisL1: 3D structure…

PDB
4FGH
Type
protein
Length
163 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dihydrofolate reductase
EC
1.5.1.3
UniProt
P0A017
Ligands
NAP, 0U6
Pockets
1 · best druggability 0.69

Structure

x-ray diffraction · 1 distinct chain · 19% helix, 36% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADihydrofolate reductase (EC 1.5.1.3)protein16319% helix, 36% strandP0A017

Ligands and binding sites

  • NAP · Nadp nicotinamide-adenine-dinucleotide phosphate · ligand · chains A
  • 0U6 · (2E)-3-{5-[(2,4-diamino-6-ethylpyrimidin-5-yl)methyl]-2,3-dimethoxyphenyl}-1-[(1S)-1-(2-methylprop-1-en-1-yl)phthalazin-2(1H)-yl]prop-2-en-1-one · ligand · chains A
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13420.690.8239NAP, 0U6

Compared structures

  • 4FGH · S. aureus dihydrofolate reductase co-crystallized with ethyl-DAP… · the same entry in another collection · chain A against A, TM-score 1.00
  • P0A017 · AlphaFold monomer V2.0 prediction for dihydrofolate reductase (P0A017) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.